カナダ投資規制機構による取引停止-RP

Stockhouse 05/08 08:11 ET

tsxベンチャー取引所株式メンテナンス・ブリテン

Stockhouse 2023/11/28 23:48 ET

RepliCel Announces DermaPrecise Trademark for Dermal Injector Product Line

Accesswire2021/10/27 18:00 ET

RepliCel Announces Dermal Injector Update

Accesswire2021/10/26 18:00 ET

RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy

Accesswire2021/10/17 18:00 ET

RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor

Accesswire2021/10/11 18:00 ET